Class of Stock [Axis]
Series A Preferred Stock [Member]
Series C Preferred Stock [Member]
Series B Preferred Stock [Member]
Equity Components [Axis]
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Legal Entity [Axis]
Mid-Atlantic BioTheraputics, Inc [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Website [Member]
Patents [Member]
IEM, Inc [Member]
Product and Service [Axis]
Investigational New Drug [Member]
Vesting [Axis]
Share-Based Payment Arrangement, Tranche One [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Payment Arrangement, Tranche Three [Member]
National Institute of Health Patent License One [Member]
National Institute of Health Patent License Two [Member]
Royalty [Member]
Royalty One [Member]
Related Party [Axis]
Officer [Member]
Debt Instrument [Axis]
Two Notes [Member]
13 Notes [Member]
Two Notes Payable [Member]
13 Notes Payable [Member]
Promissory Note Exchange [Member]
Title of Individual [Axis]
Directors and Officers [Member]
Short-Term Debt, Type [Axis]
Convertible Notes Payable [Member]
12-month Senior Secured Note [Member]
Award Date [Axis]
Beginning in September 2022 [Member]
Award Type [Axis]
MABT's COVID-19 Vaccine [Member]
Advisory Board [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Scenario [Axis]
Forecast [Member]
Board of Directors [Member]
Advisory Board One [Member]
Employee [Member]
Employees [Member]
Two Employees [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Exchange for Services [Member]
Long-Term Debt, Type [Axis]
Convertible Debt [Member]
Warrant [Member]
Series A Convertible Preferred Stock [Member]
Grantee Status [Axis]
Share-Based Payment Arrangement, Employee [Member]
Mid Atlantic Bi-theraputics Inc [Member]
Series A, B and C Preferred Stock [Member]
Legal Services [Member]
Warrants [Member]
Two Peoples [Member]
Convertible Senior Secured Note [Member]
Black Scholes [Member]
Board of Advisory [Member]
Three Employees [Member]
Senior Notes [Member]
Derivative Instrument [Axis]
Equity Option [Member]
Convertible Senior Secured Note Payable And Warrants [Member]
Lender Name [Axis]
Lender [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement [Table]
Statement [Line Items]
ASSETS
CURRENT ASSETS
Cash
Subscription receivable
Prepaid expenses
Funds receivable on notes payable
Total current assets
FIXED ASSETS
Property and equipment
Accumulated depreciation
Total Fixed Assets
OTHER ASSETS
Deferred offering costs
Intangible assets, net of amortization
Total other assets
Total Assets
LIABILITIES AND DEFICIENCY IN STOCKHOLDERS’ EQUITY (DEFICIT)
CURRENT LIABILITIES
Accounts payable and accrued liabilities
Convertible note payable
Liability to issue common shares
Short term convertible note payable, net of discounts
Third party short term loans, net of discounts
Short term loan
Total current liabilities
Total Liabilities
Commitments and Contingencies
Preferred Stock, Series C, 30,000,000 shares issued and outstanding
DEFICIENCY IN STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value, authorized 200,000,000 shares, zero Series A; Series B, 81,000 shares issued and outstanding
Common stock, $0.0001 par value, authorized 1,100,000,000 shares; 571,651,636 and 570,651,636 shares issued and outstanding
Additional paid-in capital
Accumulated deficit
Total deficiency in stockholders’ equity
Total Liabilities and Deficiency in Stockholders’ Equity
Temporary equity, shares issued
Temporary equity, shares outstanding
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
REVENUES, net
COST OF REVENUES
GROSS MARGIN
OPERATING EXPENSES:
General and administrative expenses
Research and development
Impairment of long-lived assets
Depreciation and amortization
Salaries
Professional fees
Total operating expenses
LOSS FROM OPERATIONS
OTHER EXPENSES
Interest expense
Loss on debt extinguishment
Total other expense
Net loss
Series C deemed dividend
Net loss to common shareholders
Loss per weighted average common share, basic and diluted
Number of weighted average common shares outstanding, basic and diluted
Balance
Balance, shares
Common shares issued for services
Common shares issued for services, shares
Common shares issued for intangible assets
Common shares issued for intangible assets, shares
Warrants issued in connection with debt
Warrants issued for services
Preferred stock Series A issued for services
Preferred stock Series A issued for services, shares
Preferred stock Series C issued for services
Preferred stock Series C issued for services, shares
Series A preferred converted to common
Series A preferred converted to common, shares
Series B preferred converted to common
Series B preferred converted to common, shares
Common shares issued for cash
Common shares issued for cash, shares
Shares issued to convert debt
Shares issued to convert debt, shares
Common shares issued for warrant exercise
Common shares issued for warrant exercise, shares
Common shares issued to settle payable
Common shares issued to settle payable, shares
Shares issued to settle debt
Shares issued to settle debt, shares
Shares issued to settle liability to issue shares
Shares issued to settle liability to issue shares, shares
Deemed dividend
Net loss
Shares issued for cash
Shares issued for cash, shares
Common shares issued to settle debt
Common shares issued to settle debt, shares
Options issued for services
Net income loss
Warrants issued with notes payable
Balance
Balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustments to reconcile net loss to net cash used in operating activities:
Share based compensation
Amortization of warrant discount
Amortization of Original Issue Discount
Amortization of debt discount
Write off of abandoned assets
Impairment of long lived assets
Changes in operating assets and liabilities
(Increase) in stock subscription receivable
Decrease in other receivable
Increase in prepaid expenses
Increase in accrued interest
Increase (decrease) in accounts payable and accrued liabilities
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets
Purchase of intangible assets
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash received for issuance of common stock
Cash received upon warrant exercise
Cash received from convertible note payable
Cash paid for deferred offering costs
Advances from related party
Repayments of related party notes payable
Payments on related party notes payable
Cash received from related party notes payable
Cash received from third party notes payable
Repayments of note payable
Net cash provided by financing activities
Net increase in cash
Net (decrease) increase in cash
CASH, beginning of period
CASH, end of period
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid in cash
Income taxes paid in cash
Non-cash financing activities:
Common shares issued for intangible assets
Common shares issued upon conversion of debt
Common shares issued upon conversion of preferred stock
Warrants issued as debt discount
Series C preferred stock deemed dividend
Common shares issued to settle liabilities
Net loss
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES
LIQUIDITY AND GOING CONCERN CONSIDERATIONS
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Notes Payable
NOTES PAYABLE
Debt Disclosure [Abstract]
CONVERTIBLE SENIOR SECURED NOTE PAYABLE
Liability To Issue Common Stock
LIABILITY TO ISSUE COMMON STOCK
Equity [Abstract]
DEFICIENCY IN STOCKHOLDERS EQUITY
Warrants
WARRANTS
Share-Based Payment Arrangement [Abstract]
OPTIONS
Equity Incentive Plan
EQUITY INCENTIVE PLAN
Investments, All Other Investments [Abstract]
FINANCIAL INSTRUMENTS
General And Administrative Expenses
GENERAL AND ADMINISTRATIVE EXPENSES
IMPAIRMENT OF LONG LIVED ASSETS
Income Tax Disclosure [Abstract]
INCOME TAXES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties [Abstract]
CONCENTRATIONS OF CREDIT RISK
Unusual or Infrequent Items, or Both [Abstract]
COVID-19 PANDEMIC AND VARIANTS
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Use of Estimates
Cash and equivalents
Prepaid expenses
Property and equipment
Intangible Assets
Impairment of Long-Lived Assets
Financial Instruments and Fair Value Measurements
Related Party Transactions
Revenue Recognition
Stock based compensation
Income Taxes
Net loss per shar
Recent Accounting Pronouncements
SCHEDULE OF STOCKHOLDERS EQUITY
SCHEDULE OF FAIR VALUE OF STOCK OPTION ASSUMPTIONS
SCHEDULE OF STOCK OPTION ACTIVITY
SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSE
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE
SCHEDULE OF EFFECTIVE RECONCILIATION INCOME TAX RATE
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES
Dilutive shares of common stock equivalents
Cash equivalents
Net loss
Accumulated deficit
Working capital
Schedule of Finite-Lived Intangible Assets [Table]
Finite-Lived Intangible Assets [Line Items]
Common stock issued to acquire license, shares
Common stock issued to acquire license
Common stock issued for services, value
Finite-Lived Intangible Assets, Remaining Amortization Period
Amortization of Intangible Assets
Common stock issued for services, shares
Cost of option
Option extension description
Payment for royalty free perpetual license
Payment for extension
Proceeds for patent license development
License transaction description
Payment of non-refundable license issue royalty
Patent expense initial amount payable
Schedule of Related Party Transactions, by Related Party [Table]
Related Party Transaction [Line Items]
Principal amount
Original issue discount
Schedule of Short-Term Debt [Table]
Short-Term Debt [Line Items]
Debt notes converted into shares of common stock
Debt face amount
Original issue discount, percentage
Proceeds from notes payable
Maturity term
Maturity extension description
Purchase of common stock warrants
Debt discount amount
Issued and outstanding common stock shares, percentage
Share Price
Debt Conversion, Converted Instrument, Amount
Short term debt terms
Notes payable interest rate
Notes Payable
Warrant loaned
Debt instrument interest rate
Debt conversion price percentage
Debt instrument conversion price per share
Accrued interest
Debt payment amount
Issuance of common stock, shares
Debt instrument original interest rate
Debt interest rate
Proceeds from convertible debt
Legal fees
Debt instrument redemption percentage
Debt conversion, original debt, amount
Debt redemption amount
Number of warrant shares
Class of warrant exercise price per share
Issuance of common stock for services, shares
Issuance of common stock for services, value
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion to common shares
Conversion to common shares, shares
no transactions
no transactions, shares
Schedule of Stock by Class [Table]
Class of Stock [Line Items]
Preferred stock, voting rights
Conversion price percentage
Redeemable price percentage
Common stock value
Debt instrument convertible conversion price
Shares issued
Warrants to purchase of common stock
Security deposit
Shares vested
Number of preferred stock converted
Perferred stock converted into common stock
Warrant maturity date
Warrant exercise price
Number of common stock to settle the liability to issue shares
Shares issued price per share
Number of common stock to settle a payable
Value of common stock to settle a payable
Shares issued
Stock Issued During Period, Value, Conversion of Convertible Securities
Exercise of warrants for services shares
Exchange of shares for services, shares
Exchange of shares for services, valued
Vesting rate description
Deemed dividend
Conversion of Stock, Shares Issued
Class of stock warrant shares
[custom:WarrantsToPurchaseOfCommonStockInExchangeForCash]
[custom:StockIssuedDuringPeriodValueExchangeForServices]
Warrants and Rights Outstanding
Warrants to purchase
Sale of common stock
Warrant term
Warrant exercise price per share
Warrant outstanding amount
Warrants outstanding
Stock Issued During Period, Value, New Issues
Exercise of warrants shares
SharesIssued
Expected term
Share price
Expected volatility rate
Exercise price
Expected dividend rate
Warrants description
Stock issued during period shares exercise of warrants
Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Options percentage
Proceeds from offering
Options vested percentage
Volatility rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Schedule Of Fair Value Of Stock Option Assumptions
Risk-free interest rate
Exercise price
Expected life
Expected volatility
Expected dividends
Schedule Of Stock Option Activity
Number of options, Beginning balance
Weighted Average Exercise Price, Beginning Balance
Number of options, Granted
Weighted Average Exercise Price, Granted
Number of options,Exercised
Weighted Average Exercise Price,Exercised
Number of options, Cancelled
Weighted Average Exercise Price, Cancelled
Number of options, Ending Balance
Weighted Average Exercise Price, Ending Balance
Weighted average exercise price, granted
Weighted-average grant date fair value
Share-based payment arrangement, expense
Number of options, Granted
Non-vested options outstanding
Aggregate intrinsic value of vested share options
Schedule Of General And Administrative Expense
Salaries
Professional fees
Other
Total general and administrative expenses
Depreciation
Indefinite lved intangble assets written off
Impairment charge
Current
Deferred
Total tax provisions
U.S. Federal statutory income tax rate
State income tax, net of federal benefit
Valuation allowance
Total
Net operating loss carry forwards
Stock based compensation
Other
Total
Less: valuation allowance
Net deferred tax assets
Deferred tax asset change in valuation allowance
Effective income tax rate percentage
Cash, FDIC insured amount
Subsequent Event [Table]
Subsequent Event [Line Items]
Number of warrant received
Debt Instrument, Interest Rate, Effective Percentage
Debt Instrument, Payment Terms
Debt Instrument, Interest Rate, Stated Percentage
Proceeds from Issuance of Debt
Debt Instrument, Unamortized Discount
Legal Fees
Monthly redemptions
Mandatory prepayment of original principal amount, percentage
Debt instrument, long term debt
Common stock shares
Common Stock, Value, Issued
Common stock value subscriptions
Common Stock, Shares, Issued
Payments to purchase common stock
Debt instrument maturity description
Subscription receivable.
Funds receivable on notes payable.
Liability to issue common shares.
Shortterm bank loans and notes payable net of discount.
Adjustments to additional paid in capital warrant issued for services.
Preferred stock issued during period value issued for service.
Preferred stock issued during period shares issued for service.
Preferred stock issued during period value issued for services.
Preferred stock issued during period shares issued for services.
Liability to issue common stock disclosure [Text Block]
Stock issued during period value conversions of convertible securities.
Stock issued during period shares conversions of convertible securities.
Stock issued during period value to convert debt.
Stock issued during period shares to convert debt.
Stock issued during period value to settle payables.
Stock issued during period shares to settle payables.
Stock issued during period value to settle debt.
Stock issued during period shares to settle debt.
Amortization of warrant discount.
Increase (decrease) in stock subscription receivable.
Payments on related party notes payable.
Proceeds from related party notes payable.
Proceeds from third party notes payable.
Noncash or part noncash common shares issued for intangible assets.
Effective income tax rate reconciliation valuation allowance.
Prepaid expenses [Policy Text Block]
Related party transactions [Policy Text Block]
Mid-Atlantic BioTheraputics, Inc [Member]
Website [Member]
Advisory Board [Member]
Board of Directors [Member]
Advisory Board One [Member]
Notes payable [Text Block]
Series A, B and C Preferred Stock [Member]
Exercise of warrants shares.
Cost of option.
IEM, Inc [Member]
Deemed dividend.
Warrants disclosure [Text Block]
General and admininstrative disclosure [Text Block]
Summary of general and administrative expense [Table Text Block]
Proceeds for license development.
Board of Advisory [Member]
Investigational New Drug [Member]
National Institute of Health Patent License One [Member]
Royalty One [Member]
13 Notes [Member]
Two Notes Payable [Member]
Warrants maturity period.
13 Notes Payable [Member]
Issued and outstanding shares percentage.
Two Notes [Member]
National Institute of Health Patent License Two [Member]
Exercise of warrants for services shares.
Legal Services [Member]
Employees [Member]
Options percentage.
Warrants outstanding.
Stock issued during period value warrant exercised.
Stock issued during period shares warrant exercised.
Common shares issued upon conversion of debt.
Warrants issued as debt discount.
Series C preferred stock deemed dividend.
MABT's COVID-19 Vaccine [Member]
Number of common sock to settle liability to issue shares.
Employee [Member]
Two Employees [Member]
Number of common stock to settle a payable.
Value of common stock to settle a payable.
Two Peoples [Member]
Warrants, description.
Warrants [Member]
Options vested percentage
Indefinite lved intangble assets written off.
Mandatory prepayment of original principal amount, percentage
Three Employees [Member]
Earnings per shares combination.
Weighted average number of shares outstanding combination.
Equity Incentive Plan [Text Block]
Working Capital.
Directors and Officers [Member]
Write-off of abandoned assets.
Warrant loaned.
Salaries.
Adjustments to additional paid-in capital warrant issued with notes payable.
Convertible Senior Secured Note [Member]
Stock issued during period shares exercise of warrants.
Mid Atlantic Bi-theraputics Inc [Member]
Warrants to purchase of common stock in exchange for cash.
Stock issued during period value exchange for services.
Class of warrant or right number of securities exchange warrants or rights.
Professional fee.
12-month Senior Secured Note [Member]
Beginning in September 2022 [Member]
Amortization Of Debt Discount.
Exchange for Services [Member]
Promissory Note [Member]
Senior Secured Notes [Member]
Stock issued during period to settle liability to issue shares.
Stock issued during period common shares issued for cash.
Stock issued during period shares to settle liability to issue.
Stock issued during period shares common shares issued for cash.
Promissory Note Exchange [Member]
Series A Convertible Preferred Stock [Member]
Lender [Member]
Convertible Senior Secured Note Payable And Warrants [Member]
Black Scholes [Member]
Assets, Current
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Property, Plant and Equipment, Net
Other Assets
Assets
Liabilities, Current
Liabilities
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Gain (Loss) on Extinguishment of Debt
Other Nonoperating Income (Expense)
Preferred Stock Dividends, Income Statement Impact
Net Income (Loss) Available to Common Stockholders, Basic
Shares, Outstanding
Dividends, Preferred Stock
IncreaseDecreaseInStockSubscriptionReceivable
Increase (Decrease) in Other Receivables
Increase (Decrease) in Prepaid Expense
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Payment of Financing and Stock Issuance Costs
Repayments of Related Party Debt
PaymentsOnRelatedPartyNotesPayable
Repayments of Notes Payable
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
NoncashOrPartNoncashCommonSharesIssuedForIntangibleAssets
PrepaidExpensesPolicyTextBlock
Property, Plant and Equipment, Policy [Policy Text Block]
Notes Payable [Default Label]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold
ProfessionalFee
Income Tax Expense (Benefit)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
Deferred Tax Assets, Tax Deferred Expense, Other
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance